Resources

First non-hormonal menopause treatment approved for use in the UK by the MHRA, with early-stage development at Stevenage Bioscience Catalyst

Research conducted by Pioneer Group in collaboration with Beauhurst into the UK life sciences landscape reveals a growing trend of investment into more mature companies. The report also highlights a persistent regional imbalance, with ‘Golden Triangle’ university spinouts attracting significantly more funding than those elsewhere.

Discovery Park has partnered with global proptech leader Equiem to launch Discover More — a purpose-built app that redefines how people work, connect, and collaborate across the 220-acre site. Home to over 180 pioneering companies working across science and technology, the new app is designed to make every tenant’s day-to-day experience more efficient and better connected, supporting an active tenant community and innovation ecosystem.

Microbiotica announces that patient recruitment is complete in its Phase 1b First-in-Human trial, COMPOSER-1, of MB310 in ulcerative colitis (UC) patients.

Call for BIA Board candidates. We are delighted to invite nominations from individuals interested in joining the BIA Board.

Cotton Mouton Diagnostics (CMD), a cutting-edge UK-based diagnostics technology company, has received a half-a-million-pound investment from CPI Enterprises as part of the Innovate UK Catapult Investment Pilot.

Brainomix, a global leader in AI-powered imaging solutions in stroke and lung fibrosis, has announced the appointment of Anna Griffin as Chief Financial Officer, filling a key leadership role within the company following its recent £14 million Series C funding round.

The BioIndustry Association (BIA) is now inviting applications for its 2026 Charity Partnership.

Rosalind brings extensive leadership experience across the health and life sciences sector. She has led the Government’s Office for Life Sciences for the last four years, bringing together the Government, the NHS, academia and industry to drive improved patient outcomes and economic growth through life sciences.

 In this blog, Abby Clark builds on a round table the BIA hosted with Chi Onwurah MP and Newcastle life science companies to explore the landscape and the drivers which make the sector strong, yet undervalued. 

LIfT BioSciences ('LIfT' or 'the Company')today announces a grant of €12 million has been awarded from Ireland's Disruptive Technologies Innovation Fund

Members of the Industry Skills Accelerator (ISA) have celebrated a successful year of strengthening the UK’s medicines manufacturing workforce.

We're pleased to announce the appointment of Livija Deban, Chief Scientific Officer at Prokarium, as Chair of its Engineering Biology Advisory Committee (EBAC).

CGT Catapult, an independent technology and innovation organisation specialising in the advancement of the cell and gene therapy industry, has appointed Dr Jim Faulkner as its new Chairman, effective from 29th July 2025.

In this blog, Martin Turner, Director of Policy and External Affairs at BIA, reflects on the long-anticipated Life Sciences Sector Plan and what it means for scaling UK biotech. This is the first in a series of blogs that will be released in the coming weeks.

In my final summer update as BIA CEO, I reflect on 12 amazing years and look ahead to my new role as Executive Chair of the Office for Life Sciences. This week we’ve also published our latest finance report, and we’re hiring - so if you’re looking for your next challenge, now’s the time to join Team BIA.

The UK government has officially launched its landmark Life Sciences Sector Plan, backed by over £2 billion in public funding and spearheaded by the Department for Science, Innovation and Technology, Business and Trade, and Health and Social Care.

The BioIndustry Association today publishes new data revealing that the UK’s life sciences sector attracted £1.23 billion in venture capital (VC) investment in the first half of 2025, thereby putting it on track to match or surpass 2024’s total.

In this blog, Linda Bedenik, Senior Policy and Public Affairs Manager at BIA, shares insights from the BIA's first-of-its-kind funding and investment analysis into UK Deep Biotech.